To identify the specific molecules that regulate REV1, we first treated lung cancer cells with MG132 and found that REV1 expression was significantly upregulated, suggesting that REV1 may be regulated by the ubiquitin-proteasome system (Fig. 6A). Here, REV1 is linked to lung carcinoma.